| |
|
|
|
Xtalks, Online
2025-10-23
Formulators face increasing pressure to create safe and stable products without introducing new or untested ingredients. Proven components, such as benzalkonium chloride (BKC), offer a solution that supports antimicrobial control while also contributing to stability and shelf life in multi-dose pharmaceuticals. This webinar will include comparative analyses of antimicrobials and will explore how BKC’s established capabilities to help prevent infections, strengthen formulations and enhance patient safety at the right concentrations.
BKC has a long history of use in ophthalmic, nasal and topical products. It is a reliable antimicrobial surfactant effective against a broad spectrum of microorganisms, even at very low concentrations. This enables strong protection while minimizing irritation and supporting patient comfort.
The featured speaker will present results of antimicrobial effectiveness testing for acne and ophthalmic applications. Attendees will learn how to determine safe and effective concentrations of BKC, extract learnings from cross-analysis with other antimicrobials and understand why BKC remains a versatile and stable option for modern formulations.
Register for this webinar to discover how benzalkonium chloride can enhance pharmaceutical formulations through proven efficacy, stability and patient safety.
Keywords: Active Pharmaceutical Ingredient, Antimicrobial, API/Formulation Development, Bacteria, CDMO/CMO, Drug Development, Formulation, Patient Experience, Preservatives, Product Development
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Chantale Julien, Global Product Manager, Novo Nordisk Pharmatech A/S
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2025-10-23
|
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|